Gemcitabine

ATC CODE

  • L01BC05

INDICATIONS AND NEMLC RECOMMENDATIONS

INDICATIONS AND NEMLC RECOMMENDATIONS 1

INDICATION

  • Pancreatic cancer.

NEMLC RECOMMENDATION

  • Not Approved

REVIEW INDICATORS

  • Reduction in cost of gemcitabine.

DATE RATIFIED

  • 29 October 2012


INDICATIONS AND NEMLC RECOMMENDATIONS 2

INDICATION

  • First-line chemotherapy in advanced non-small cell lung cancer (NSCLC) in patients intolerant to paclitaxel.

NEMLC RECOMMENDATION

  • Approved
    Approved in patients intolerant to paclitaxel.

REVIEW INDICATORS

  • n/a

DATE RATIFIED

  • 22 January 2015


INDICATIONS AND NEMLC RECOMMENDATIONS 3

INDICATION

  • Relapsed metastatic breast cancer (mBC) failing an anthracycline and a taxane

NEMLC RECOMMENDATION

  • Approved

REVIEW INDICATORS

  • n/a

DATE RATIFIED

  • 15 September 2016